CEN Biotech, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CENBF research report →
Price Chart
About the company
CEN Biotech, Inc. specializes in the creation, production, and ongoing development of both LED lighting technology and goods made from hemp. The company's future plans include cultivating hemp for use across various sectors, including industrial, medical, and food applications.
- CEO
- Brian S. Payne
- IPO
- 2020
- Employees
- 4
- HQ
- Windsor, ON, CA
Get TickerSpark's AI analysis on CENBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.05K
- P/E
- -0.01
- PEG
- -0.00
- P/S
- 0.01
- P/B
- -0.01
- EV/EBITDA
- -6.67
- Div Yield
- 0.00%
- Gross Margin
- 50.45%
- Op Margin
- -128.15%
- Net Margin
- -153.48%
- ROE
- 76.72%
- ROIC
- -43.09%
Latest fiscal year · YoY change
- Revenue
- $987.11K+57.5%
- Gross Profit
- $498.00K-20.6%
- Op Income
- $-1,265,000
- Net Income
- $-1,515,000+92.0%
- EPS
- $-0.02+94.8%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -4.98
- RSI (14)
- 43
- Avg Volume
- 314
No earnings-call transcripts are available for CENBF yet.
- Free Float
- 49.8%
- Shares Outstanding
- 65.26M
- Float Shares
- 32.48M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 6, 21 | Purdy Rick Leigh | other | 2,500,000 |
| Jul 9, 21 | Lehoux Lawrence | other | 0 |
| Jun 16, 21 | Tarrabain Alex | other | 3,000 |
| Jun 25, 21 | Tarrabain Alex | other | 1,000,000 |
| Apr 2, 21 | Aubrey de Lavenu Harold Andre | other | 1,041,250 |
| Apr 2, 21 | Strilchuck Donald | other | 341,250 |
| Apr 2, 21 | Saadikh Usamakh | other | 1,000,000 |
| Apr 19, 21 | Byrne Joseph A. | other | 0 |
| Apr 19, 21 | Byrne Joseph A. | other | 0 |
| Aug 17, 16 | Byrne Joseph A. | other | 76,123 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CENBF coverage
Recent articles, reports, and earnings notes.
No research on CENBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CENBF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.